PRODUCT DATA SHEET TRANSGLUTAMINASE MICORASSAY KIT, COLORIMETRIC
Kit produced and Developed by CovalAb, France
TABLE OF CONTENTS
INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN
HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.
ZEDIRA GmbH, Roesslerstr. 83, D-64293 Darmstadt, Germany; +49 (0)6151-325100 Product No.: T054 Introduction
Transglutaminases (EC. 2.3.213, R-glutamyl-peptide: amine γ-glutamyltransferase) are a family of calcium dependent enzymes which catalyse an acyl transfer reaction between the γ-carboxamide group of peptide bound glutamine and various primary amines. The ε-amino group of lysine residues as well as some polyamines are the physiological amine donors, but some non-physiological amines can also be used by the enzyme. In vertebrates, transglutaminases (TGases) are widely distributed in various organs, tissues and body fluids. TGases are involved in a variety of roles including blood clotting, formation of the cornified envelope of the epidermis and its appendages (hair, nail, callus), stabilization of intra and extra cellular matrices and cross-linking of cell envelopes in apoptosis. All the enzymatic assays for TGases referred to above were carried out under optimal conditions of pH, Ca2+ and substrates with dimethylcasein as the first substrate and radiolabelled putrescine or dansyl cadaverine as the second substrate. Another approach to quantitating TGase activity has been to measure ammonia released during isopeptide bond formation. These techniques are time consuming and labor intensive. To completely overcome these problem we have developed a three labor step solid phase micro assay: “TG-Covtest” Principle of the assay The TG-Covtest uses CBZ-Gln-Gly as the first substrate (amine acceptor) and biotin cadaverine as second (amine donor). In the 1st step, samples suspected of containing TGase are incubated with calcium, dithiothreitol (DTT) and biotinylated cadaverine in the wells of microtiter plates to which CBZ-Gln-Gly had been covalently coupled previously. In the presence of TGase biotinylated cadaverine is incorporated γ-carboamyde of the glutaminyl residue of the dipeptide to form γ-glutamyl cadaverine biotin. In the second step streptavidin-labelled peroxidase is added to the wells. In the third step, peroxidase activity is revealed using H2O2 as HRP substrate and tetramethyl benzidine as electron acceptor (chromogen). The TG-Covtest has two original features:
The use of covalently coupled CBZ-Gln-Gly solves the problem of leaching out of absorbed substrate
The second feature is that 96 samples can be simultaneously screened in 30 minutes time.
Other supplies required
Microplate reader capable of measuring absorbance at 450 nm. Pipettes, multi-channel pipette, and pipette tips. Ultra-pure or deionized water Squirt bottle, manifold dispenser, or automated microplate washer.
ZEDIRA GmbH, Roesslerstr. 83, D-64293 Darmstadt, Germany; +49 (0)6151-325100 Product No.: T054 Reagents of the Kit
Reagents Quantity
R1: Microtiter plates with covalently bound CBZ-Gln-Gly
R3: Biotin-cadaverine/CaCl2 (lyophilized powder)
The Kit contains also recombinant tissue transglutaminase (Zedira, T058) for calibration purposes. Storage and Preparation of Reagents
R1: Microtiter plates with covalently bound CBZ-Gln-Gly The plates should be kept at +4°C and are ready to use. R2: Negative control The negative control should be kept at +4°C and is ready to use. The negative control contains EDTA which inhibits the TGase activity. R3: Biotin-cadaverine/CaCl2 Lyophilized powder should be kept at -20°C. Lyophilised powder should be reconstituted with 6,5 mL of distilled water just before use. Unused solution should not be stored more than 4 hours at +4°C. R4: Enzyme tracer Enzyme tracer should be kept at –20°C. Enzyme tracer should be diluted at 1/2000 with 1X diluent buffer just before use. Unused solution should be eliminated R5: Diluent buffer 10X The diluent buffer 10X should be kept at +4°C. Dilu ent buffer 10X should be diluted at 1/10 with distilled water just before use. R6: HRP substrate / R7: Chromogen The reagents should be kept at +4°C. 1 drop of chro mogen should be added to 2 mL of HRP substrate just before use. R8: Blocking reagent Blocking reagent should be kept at +4°C and is read y to use.
Preliminary Operations
1. Identify a sufficient number of wells to run in duplicate:
b) the positive control (TGase + distilled water)
c) the negative control (TGase + R2 reagent)
Controls and samples should all be subjected to exactly the same assay procedure. Keep one blank well for HRP substrate/chromogen solution only.
2. Dispense 150 µL per well of 1x diluent buffer and incubate the plate for at
3. Prepare the samples: samples from cells or tissues should be centrifuged
Perform the TG-Covtest as follows
Remove the 1X diluent buffer from the plate.
Per well, dispense the samples* (50 µL), dispense the positive control
(40 µL TGase +10 µL distilled water) and dispense the negative control
Dispense 50 µL per well of reconstituted biotin-cadaverine/CaCI2
Prepare the enzyme tracer solution at 1/2000.
Wash the wells three times with Phosphate Buffered Saline containing
0,1% Tween 20 or Tris Buffered Saline containing 0,1% Tween 20.
Dispense 100 µL per well of 1/2000 diluted enzyme tracer solution.
Prepare the HRP substrate/chromogen solution.
Wash the wells three times with Phosphate Buffered Saline containing
0,1% Tween 20 or Tris Buffered Saline containing 0,1% Tween 20.
Dispense 100 µL per well of HRP substrate/chromogen solution.
Incubate for 2 to 10 min at room temperature.
Dispense 50 µL per well of blocking reagent.
Measure the optical density of each well at 450nm (OD450nm).
*Please note that it could be better to treat the samples as controls: - active TGase sample: (40 µL sample + 10 µL distilled water) per well, - inactive TGase sample: (40 µL sample + 10 µL R2 reagent) per well.
ZEDIRA GmbH, Roesslerstr. 83, D-64293 Darmstadt, Germany; +49 (0)6151-325100 Product No.: T054 Calculation of Results Several experiments using purified guinea pig TGase (Activity: 2 units per mg protein) have shown that 1.25 mU/mL (final concentration) correspond to an absorbance value of 1+ 0.05 OD at 450 nm. 1 unit will catalyze the formation of 1µmole of hydroxamate at pH 6.0 at 37°C, using L-glutamic acid γ-monohydroxamate as the standard (Folk and Cole, 1966). If other TGase standards are used in this assay the reference value may be different. End user should establish their own set of reference values. Safety Procedures The product is not licensed or approved for administration to humans or to animals. Standard Laboratory Practices should be followed when handling this material. Handle with care HRP substrate (R6), chromogen (R7) and blocking reagent (R8). R6, R7 and R8 reagents are irritating to eyes and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Comparison of colorimetric and radiometric FXIII assays
ZEDIRA GmbH, Roesslerstr. 83, D-64293 Darmstadt, Germany; +49 (0)6151-325100 Product No.: T054 References
1.
Folk JE and Finlayson JS. The -glutamyl)lysine cross link and the catalytic role of transglutaminases. Advances in Protein Chemistry, 1977, 31: 1-33.
El Alaoui S. and al. Transglutaminase activity and N -glutamyl)lysine isopeptides levels in cells during growth in culture, an enzymatic and
immunological study.Int. J. Cancer, 1992, 48,221-226.
El Alaoui S. and al. Evaluation of a novel colorimetric solid phase micro-assay
for plasma Factor XIII. Blood Coagulation and Fibrinolysis, 199, 3, 803-811
Jeon, W.M. et al. Colorimetric assay for cellular transglutaminase. Anal.
Lorand L and al, A filter paper assay for transamidating enzymes using radioactive amine substrate. Anal . Biochem., 1972; 50, 623-631.
Thomas F. and al. A microtiter plate transglutaminase Assay utilizing 5-(Biotinamido)pentylamine as substrate, Anal. Biochem., 1992, 205, 166-171.
Villalobos E. and al. Molecular cloning and characterization of a maize transglutaminase complementary DNA. Gene 336., 2004, 93-104.
Thomas V. and al. Development and evaluation of a modified colorimetric solid-phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminases Biotechnol. Appl. Biochem. (2006) 43, 171–
ZEDIRA GmbH, Roesslerstr. 83, D-64293 Darmstadt, Germany; +49 (0)6151-325100 Product No.: T054
An Independent Licensee of the Blue Cross and Blue Shield Association 450 Riverchase Parkway East, Birmingham, AL 35244 Drug Class Generic drugs Preferred Brand drugs Drugs not covered amphetamine/dextroamphetamine (Adderall), amphetamine/dextroamphetamine ER (Adderall XR), dexmethylphenidate (Focalin), dextroamphetamine, ATTENTION-DEFICIT ADDERALL,ADDERALL XR,
REGIONALE TOETSINGSCOMMISSIE EUTHANASIE van de Regionale toetsingscommissie euthanasie voor de regio (.) betreffende de melding van levensbeëindiging op verzoek van: mevrouw (.) (.) (.), (.) gevestigd te (.) verder te noemen: de arts bij: de heer (.) (.) (.) geboren op (.) overleden op (.) te (.) verder te noemen: patiënt geconsulteerd werd: de heer (.) gevestigd te (.) verder te noem